Our Mission: Cure Desmoid Tumors
The Desmoid Tumor Research Foundation (DTRF) empowers and unites everyone committed to finding answers for the desmoid tumor community. We aggressively fund desmoid tumor research, accelerate the development of improved therapies, drive collaborations among clinicians and researchers worldwide, and support patients and doctors through education. Our goal is to find a cure for each and every patient diagnosed with this rare disease.
Learn more about submitting a grant proposal.
EXPLORE THE RESEARCH WE’VE FUNDED AT PRESTIGIOUS INSTITUTIONS AROUND THE WORLD.
| Year | Principal Investigator | Award Title | |
|---|---|---|---|
| Year2022 | Principal InvestigatorSameer Rastogi, MD, All India Institute of Medical Sciences | Award Title“To see the early effect of sorafenib on cognition, cardiovascular and reproductive functions in patients with fibromatosis.” Year 1 of 3 | View Project |
| Year2022 | Principal InvestigatorGerlinde Wernig, MD, Stanford School of Medicine, Department of Pathology | Award Title“Studying CD47 blockade as an immunotherapy for desmoid-type fibromatosis.” Year 2 of 2 | View Project |
| Year2022 | Principal InvestigatorKris Vleminckx, PhD, Ghent University | Award Title“Investigating EZH2 as a druggable mediator of immune cell exclusion in desmoid tumors.” Year 2 of 2 | View Project |
| Year2021 | Principal InvestigatorManon N.G.J.A. Braat, MD, Dept of Radiology, University Medical Center Utrecht | Award Title“Magnetic resonance image-guided high intensity focused ultrasound for patients with desmoid-type fibromatosis: the MAGNIFIED trial.” Year 1 of 2 | View Project |
| Year2021 | Principal InvestigatorKris Vleminckx, PhD, Ghent University | Award Title“Investigating EZH2 as a druggable mediator of immune cell exclusion in desmoid tumors.” Year 1 of 2 | View Project |
| Year2021 | Principal InvestigatorGerlinde Wernig, MD, Stanford School of Medicine, Department of Pathology | Award Title“Studying CD47 blockade as an immunotherapy for desmoid-type fibromatosis.” Year 1 of 2 | View Project |
| Year2020 | Principal InvestigatorKris Vleminckx, PhD, Ghent University | Award Title“Identifying and characterizing dependency factors in a genetic Xenopus tropicalis desmoid tumor model.” Year 2 of 2 | View Project |
| Year2020 | Principal InvestigatorJesse Boehm, PhD, Associate Director of the Cancer Program, Director of the Cancer Cell Line Factory, Principal Investigator in the Cancer Model Development Center, Institute Scientist, The Broad Institute of MIT and Harvard | Award Title“Using genome-scale CRISPR screening to create a desmoid tumor dependency map.” Year 2 of 3 | View Project |
| Year2019 | Principal InvestigatorGerlinde Wernig, MD, Stanford School of Medicine | Award Title“c-Jun-inducible mice, to study the pathomechanism of desmoid-type fibromatosis in vivo with particular attention to the role of b-catenin/wnt and Notch pathways.” Year 2 of 2 | View Project |
| Year2019 | Principal InvestigatorKris Vleminckx, PhD, Ghent University | Award Title“Identifying and characterizing dependency factors in a genetic Xenopus tropicalis desmoid tumor model.” Year 1 of 2 | View Project |
Clinicians & Researchers Newsletter
Receive monthly updates about treatment advances, grant applications, clinical trials, CME opportunities, and more.
